Thursday, 20 September 2018

Stephen Lacey' s stories

Sort by: Newest firstOldest firstA-ZZ-A

  • Tenable secures beachhead with US$250m IPO

    Equities | 27 July 2018

    Tenable, the latest incumbent in the war on cyber terrorism, raised an upsized US$250.7m on its IPO.

  • Cushman & Wakefield gains strategic push on US$810m IPO

    Equities | 27 July 2018

    Cushman & Wakefield is garnering plenty of attention from investors on its up to US$810m IPO.

  • Berry Petroleum sours on IPO

    Equities | 27 July 2018

    Berry Petroleum, the one-time subsidiary of bankrupt Linn Energy, weathered a tough slog on its reintroduction to the public markets.

  • Berry Petroleum ripens for IPO return

    Equities | 20 July 2018

    Once bankrupt, Berry Petroleum is taking a conservative approach in its return to public markets by promising to live within cashflow and agreeing to pay a dividend to shareholders as proof of its discipline.

  • Tilray blazes trail with cannabis IPO

    Equities | 20 July 2018

    Tilray, a Canada-domiciled grower of cannabis, blazed a new trail on Thursday by becoming the first cannabis company to go public on a major US stock exchange.

  • AFG tells investors to frack off

    Equities | 20 July 2018

    AFG Global, an oilfield services company that recently emerged from bankruptcy, balked at terms presented to it on its IPO on Wednesday rather than proceed with the stigma of a flawed process.

  • hemp cannabis

    Canadian weed grower rolls up at Nasdaq

    Top News | 13 July 2018

    The business of growing cannabis on an industrial scale is being led by Canadians, after the federal government last month moved ahead with measures to legalise recreational consumption of the drug across the country from October.

  • Palo Alto Networks

    Palo Alto lands US$1.5bn from year's biggest CB

    Top News | 13 July 2018

    The US convertible bond market has taken on an element of wash, rinse and repeat, with Palo Alto Networks the latest tech company to take the dip with an opportunistic US$1.5bn five-year CB, the largest CB this year.

  • Spero administers dilution antidote

    Equities | 13 July 2018

    Spero Therapeutics, a pre-clinical biotech, went back to the drawing board to rework the terms but still managed to raise US$75m from a marketed follow-on offering.

  • Shopping mall

    Chile's Mallplaza readies rare LatAm IPO

    Ticker | 12 July 2018

    Chile’s Mallplaza could break the long lull in the Latin American IPO market at it prepares to go public with an approximately US$575m issue, a source told IFR on Thursday.